Topics:
Radiation Oncology • Genitourinary Cancers
Why are patients getting enzalutamide s/p prostatectomy not candidates for salvage radiation therapy?
On the EMBARK trial (Freedland et al., NEJM 2023), 25% of men had a prostatectomy and the publication states "Patients were excluded … if after radical prostatectomy they were considered by the investigator to be a candidate for salvage radiation therapy." Why was salvage radiation therapy excluded?